Adaptive Biotechnologies Corp. (ADPT)
25.51
+1.10
(+4.51%)
USD |
NASDAQ |
Oct 23, 16:00
25.50
-0.01
(-0.04%)
After-Hours: 20:00
Adaptive Biotechnologies Market Cap : 4.058B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.058B |
| October 22, 2026 | 3.883B |
| October 21, 2026 | 4.029B |
| October 20, 2026 | 3.884B |
| October 19, 2026 | 3.809B |
| October 16, 2026 | 3.821B |
| October 15, 2026 | 4.069B |
| October 14, 2026 | 4.075B |
| October 13, 2026 | 4.021B |
| October 12, 2026 | 4.067B |
| October 09, 2026 | 4.213B |
| October 08, 2026 | 4.150B |
| October 07, 2026 | 4.180B |
| October 06, 2026 | 4.279B |
| October 05, 2026 | 4.746B |
| October 02, 2026 | 4.509B |
| October 01, 2026 | 4.353B |
| September 30, 2026 | 4.597B |
| September 29, 2026 | 4.576B |
| September 28, 2026 | 4.535B |
| September 25, 2026 | 4.681B |
| September 24, 2026 | 4.703B |
| September 23, 2026 | 4.436B |
| September 22, 2026 | 4.463B |
| September 21, 2026 | 4.431B |
| Date | Value |
|---|---|
| September 18, 2026 | 4.551B |
| September 17, 2026 | 4.541B |
| September 16, 2026 | 4.401B |
| September 15, 2026 | 4.244B |
| September 14, 2026 | 3.941B |
| September 11, 2026 | 3.849B |
| September 10, 2026 | 3.854B |
| September 09, 2026 | 3.884B |
| September 08, 2026 | 3.872B |
| September 04, 2026 | 3.862B |
| September 03, 2026 | 3.908B |
| September 02, 2026 | 3.922B |
| September 01, 2026 | 3.872B |
| August 31, 2026 | 3.964B |
| August 28, 2026 | 4.007B |
| August 27, 2026 | 4.206B |
| August 26, 2026 | 4.161B |
| August 25, 2026 | 4.175B |
| August 24, 2026 | 4.064B |
| August 21, 2026 | 4.134B |
| August 20, 2026 | 4.046B |
| August 19, 2026 | 4.054B |
| August 18, 2026 | 3.907B |
| August 17, 2026 | 3.940B |
| August 14, 2026 | 3.935B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Champions Oncology, Inc. | 65.70M |
| Medpace Holdings, Inc. | 18.67B |
| Avantor, Inc. | 11.70B |
| Personalis, Inc. | 1.686B |
| 10X Genomics, Inc. | 9.322B |
Market Cap Related Metrics
| PS Ratio | 13.08 |
| Price to Book Value | 28.39 |
| Price | 25.51 |
| Earnings Yield | -1.60% |